Nokia Corp vs TransMedics Group Inc — how do they compare? Nokia Corp trades at $11.08 (market cap $56.70B), while TransMedics Group Inc trades at $74.3 (market cap $2.54B). The key difference: Nokia Corp is far larger — about 22.3× TransMedics Group Inc's market cap, and Nokia Corp pays a 1.63% dividend while TransMedics Group Inc pays none. Which is the better fit depends on your goals.
| NOK | TMDX | |
|---|---|---|
Market Cap | $56.70B | $2.54B |
Sector | Technology | Technology |
52-Week High | $16.83 | $150.42 |
52-Week Low | $4.05 | $61.99 |
Enterprise Value | $53.51B | $2.94B |
Dividend Yield | 1.63% | — |
Signals from Pluang's Aura AI — not financial advice
Nokia (NOK) trades at $10.65, up 5.24% on the day, with a bullish analyst consensus price target of $18.00 representing significant upside. Recent earnings show mixed results with a Q1 2026 miss but Q3 and Q4 2025 beats. The company is pivoting toward AI and 5G infrastructure, evidenced by new partnerships and strong revenue growth in these segments. Technical indicators are mixed, with oscillators bullish but moving averages bearish, suggesting near-term consolidation.
The outlook is cautiously optimistic, driven by AI networking demand and strategic deals, but risks include intense competition and execution challenges. Valuation appears stretched with a P/E of 63.22, requiring sustained earnings growth to justify current levels. The stock offers potential for long-term growth if AI initiatives deliver, but near-term volatility is likely.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Nokia is a leading vendor in the telecommunications equipment industry. The company's network business derives revenue from selling wireless and fixed-line hardware, software, and services. Nokia's technology segment licenses its patent portfolio to handset manufacturers and makes royalties from Nokia-branded cellphones. The company, headquartered in Espoo, Finland, operates on a global scale, with most of its revenue from communication service providers.
Read more on NOK →TransMedics is a pioneering medical technology company that is disrupting the organ transplant market with its Organ Care System (OCS™). By replacing traditional cold storage with portable warm perfusion, the OCS maintains donor organs in a near-physiologic state, allowing for continuous assessment and optimization. Through its National OCS Program (NOP™), TransMedics provides an end-to-end clinical and logistics solution, including a dedicated aviation fleet, to maximize the utilization of donor organs and improve patient outcomes.
Read more on TMDX →